We are live on !
Find out more
TOBAM Portfolio holdings
AUM
$244M
Turnover
23.99%
1-Year Est. Return
22.99%
This Fund
S&P 500
This Quarter Est. Return
+5.67%
1 Year Est. Return
+22.99%
3 Year Est. Return
+76.51%
5 Year Est. Return
+69.97%
10 Year Est. Return
+288.16%
AUM
$3.02B
AUM Growth
-$517M
(-15%)
Cap. Flow
-$664M
Cap. Flow % of AUM
Cap. Flow %
-22%
Top 10 Holdings %
Top 10 Hldgs %
32.13%
Holding
158
New
26
Increased
40
Reduced
69
Closed
23
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$75.6M |
| 2 |
SLXP
Salix Pharmaceuticals
SLXP
|
+$53M |
| 3 |
Coca-Cola
KO
|
+$51.7M |
| 4 |
Genworth Financial
GNW
|
+$49.3M |
| 5 |
VER
VEREIT
VER
|
+$43.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Quest Diagnostics
DGX
|
+$109M |
| 2 |
HP
HPQ
|
+$82.4M |
| 3 |
ESRX
Express Scripts Holding
ESRX
|
+$68.2M |
| 4 |
Intuitive Surgical
ISRG
|
+$58.9M |
| 5 |
Exelon
EXC
|
+$55.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 15.55% |
| 2 | Consumer Staples | 14.94% |
| 3 | Utilities | 12.81% |
| 4 | Technology | 12.56% |
| 5 | Consumer Discretionary | 9.66% |
Similar funds
WAM
QAM
TOBAM's Q4 2014 Portfolio in Review
As of Q4 2014, TOBAM held 158 positions worth $3.02B, down 15% from $3.54B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
TOBAM withdrew a net $664M in Q4 2014, closing 23 positions and reducing 69 holdings. Its most notable exit was Endo International, an estimated $49.1M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 16% of assets, up from 12% a quarter earlier, followed by Consumer Staples and Utilities.
Against the trend, TOBAM opened a new position in Salix Pharmaceuticals worth $50.3M.
- TOBAM's largest Q4 2014 buy was Salix Pharmaceuticals: 437,377 shares worth $50.3M.
- TOBAM added most to Clorox in Q4 2014, an estimated $75.6M increase.
- TOBAM's biggest Q4 2014 reduction was Quest Diagnostics, cutting an estimated $109M.
- TOBAM fully exited Endo International in Q4 2014, selling an estimated $49.1M.
- TOBAM's ten largest holdings make up 32% of its $3.02B portfolio in Q4 2014.
- TOBAM opened 26 new positions and closed 23 in Q4 2014.
- TOBAM's portfolio value fell 15% quarter-over-quarter to $3.02B.
Based on TOBAM's 13F filing for Q4 2014, filed 20 Feb 2015.